Health Technology News

Discover the latest in health technology with press releases highlighting innovations, trends, and applications driving digital health. Stay informed on key developments in health tech and explore opportunities in medical devices, telemedicine, and IT solutions.

Jul 27, 2026 at 12:00 PM

SCIEX Helps Clinical Labs Move From Sample to Answer Faster With New Software and LC Solutions

MARLBOROUGH, Mass.--(BUSINESS WIRE)--SCIEX helps clinical labs move from sample to answer faster with new software and LC solutions....
Jul 27, 2026 at 10:56 AM

Neuvotion Announces Commercialization of Brain-Computer Interface and Brain-Body Interface Technologies – Related Clinical Study Published in Nature Medicine

STAMFORD, Conn.--(BUSINESS WIRE)--Neuvotion, Inc. is an early-stage medical device company developing an AI-guided neuromodulation platform to accelerate recovery after neurological events such as stroke and spinal cord injury. Its Brain-Body Interface (BBI) portfolio integrates wearable high-resolution muscle stimulation, spinal neuromodulation, and minimally invasive brain-computer interface (BCI) technologies to restore movement and sensation. By combining AI, intention-driven neurostimulati...
Jul 27, 2026 at 10:00 AM

Massive Bio and GELL Announce Strategic Partnership to Advance Research, Medical Education, and Artificial Intelligence Across Latin America and the United States

BOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio, a global leader in artificial intelligence-driven solutions for oncology, clinical trial matching, and patient navigation, and the Latin American Study Group on Lymphoproliferative Disorders (GELL), one of the most influential scientific and academic networks dedicated to lymphomas and hematologic malignancies in Latin America, today announced a strategic partnership focused on advancing clinical research, physician education, and innovation throu...
Jul 27, 2026 at 9:00 AM

Dopl Technologies Raises $6.3M in Seed Funding to Advance Proprietary Telerobotic Ultrasound Toward FDA Clearance

BOTHELL, Wash.--(BUSINESS WIRE)--Dopl Technologies, a Bothell, Washington-based medical technology company developing a robotic ultrasound platform, today announced it has closed a $6.3 million seed round led by SpringTide Ventures. The round raised Dopl's total funding to more than $8 million. Its investor base includes more than a dozen firms, comprising strategic, institutional, and community-focused investors from across the United States. With the new funding, Dopl will pursue FDA clearanc...
Jul 27, 2026 at 8:08 AM

bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung

SAN ANTONIO--(BUSINESS WIRE)--BIAF publishes CyPath Lung white paper which presents clinical protocols for lung nodule evaluation, lung cancer patient care & survivor surveillance....
Jul 27, 2026 at 8:00 AM

Varex Schedules Third Quarter Fiscal Year 2026 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--VAREX SCHEDULES THIRD QUARTER FISCAL YEAR 2026 EARNINGS RELEASE AND CONFERENCE CALL...
Jul 27, 2026 at 8:00 AM

Leerink Partners Report Names Carterra a Core Enabler of the $7B "Lab-in-the-Loop" Antibody Discovery Market

SALT LAKE CITY--(BUSINESS WIRE)--Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR) platforms for antibody and small molecule discovery, today highlighted new research from Leerink Partners identifying Carterra as a key enabling technology in the fast-growing market for AI-driven biologics drug discovery. In a report published July 16, 2026, titled "Lab-in-the-Loop: AI Rewires Antibody Discovery, Unlocking a $7B LST Opportunity," Leerink Partners analyst Puneet...
Jul 27, 2026 at 8:00 AM

Novanta Completes Acquisition of Riverpoint Medical

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today announced that it has completed the acquisition of Riverpoint Medical (“Riverpoint Medical” or “Riverpoint”) from Arlington Capital Partners. Riverpoint is a category leader in high-growth minimally invasive surgical consumables, including advanced surgical fibers and related technologies for sports medicine, trauma and...
Jul 27, 2026 at 7:00 AM

Liberate Bio Appoints Steven H. Bernstein, M.D., as Chief Medical Officer to Advance In Vivo Cell Programming Toward the Clinic

BOSTON--(BUSINESS WIRE)--Liberate Bio, Inc., a biotechnology company developing genetic medicines that program immune cells directly inside the body, today announced the appointment of Steven H. Bernstein, M.D., as Chief Medical Officer, effective July 13, 2026. Dr. Bernstein joins Liberate as the company advances its myeloid-selective, liver-detargeted lipid nanoparticle platform and lead in vivo CAR-M programs toward first clinical evaluation. In this role, he will lead clinical development s...
Jul 24, 2026 at 4:31 PM

Biointron Launches RushData, an Integrated Platform for AI-Driven Antibody Discovery with 1-Day CHO Expression

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biointron has launched RushData, a platform integrating 1-day CHO expression with antibody assays for structured, AI-ready data delivery....
Turn Your News Into Headlines
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up